Tevogen Inc.
TVGN
$7.34
$0.010.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -47.29% | -49.79% | -32.21% | 16.63% | 30.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.51% | -38.42% | -51.20% | -33.15% | -26.39% |
| Operating Income | 31.51% | 38.42% | 51.20% | 33.15% | 26.39% |
| Income Before Tax | 30.73% | 39.61% | -91.41% | -292.20% | -425.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.73% | 39.61% | -91.41% | -292.20% | -425.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.73% | 39.61% | -91.41% | -292.20% | -425.62% |
| EBIT | 31.51% | 38.42% | 51.20% | 33.15% | 26.39% |
| EBITDA | 31.42% | 38.66% | 51.41% | 33.28% | 26.60% |
| EPS Basic | 37.21% | 36.97% | -105.26% | -50.61% | -56.31% |
| Normalized Basic EPS | 38.35% | 44.23% | 57.12% | 47.15% | 44.09% |
| EPS Diluted | 37.21% | 37.14% | 58.37% | 54.86% | 53.65% |
| Normalized Diluted EPS | 38.35% | 44.23% | 56.28% | 46.13% | 42.98% |
| Average Basic Shares Outstanding | 10.22% | 7.64% | 9.93% | 29.27% | 38.21% |
| Average Diluted Shares Outstanding | 10.22% | 7.64% | 8.96% | 27.94% | 36.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |